Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 3
2011 3
2012 3
2013 1
2014 3
2015 3
2016 3
2017 4
2018 7
2019 1
2020 3
2021 10
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease.
Derikx LAAP, Plevris N, Su S, Gros B, Lyons M, Siakavellas SI, Constantine-Cooke N, Jenkinson P, O'Hare C, Noble C, Arnott ID, Jones GR, Lees CW. Derikx LAAP, et al. Among authors: siakavellas si. Dig Liver Dis. 2023 Aug;55(8):1034-1041. doi: 10.1016/j.dld.2022.10.002. Epub 2022 Oct 22. Dig Liver Dis. 2023. PMID: 36283944 Free article.
The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.
Siakavellas SI, Sfikakis PP, Bamias G. Siakavellas SI, et al. Semin Arthritis Rheum. 2015 Aug;45(1):1-8. doi: 10.1016/j.semarthrit.2015.02.007. Epub 2015 Feb 20. Semin Arthritis Rheum. 2015. PMID: 25887448 Review.
Markers of bacterial translocation in end-stage liver disease.
Koutsounas I, Kaltsa G, Siakavellas SI, Bamias G. Koutsounas I, et al. Among authors: siakavellas si. World J Hepatol. 2015 Sep 18;7(20):2264-73. doi: 10.4254/wjh.v7.i20.2264. World J Hepatol. 2015. PMID: 26380651 Free PMC article. Review.
Real-world effectiveness and safety of ustekinumab for the treatment of Crohn's disease: the Scottish ustekinumab cohort.
Plevris N, Fulforth J, Siakavellas S, Robertson A, Hall R, Tyler A, Jenkinson PW, Campbell I, Chuah CS, Kane C, Veryan J, Lam WL, Saunders J, Kelly C, Gaya D, Jafferbhoy H, Macdonald JC, Seenan JP, Mowat C, Naismith G, Potts LF, Sutherland DI, Watts D, Arnott I, Bain G, Jones G, Lees CW. Plevris N, et al. Among authors: siakavellas s. J Gastroenterol Hepatol. 2021 Aug;36(8):2067-2075. doi: 10.1111/jgh.15390. Epub 2021 Mar 5. J Gastroenterol Hepatol. 2021. PMID: 33381875
48 results